Cardiology Headline News

Dietary acid reduction from fruits and vegetables or sodium bicarbonate improved kidney health in patients with hypertension and macroalbuminuria, findings from a randomized controlled trial showed.

SGLT2 inhibitors were associated with similar renal and CV outcomes vs. GLP-1 receptor agonists for patients with diabetes, regardless of chronic kidney disease status, researchers reported.

In an analysis of more than 3 million U.S. adults, most patients with a class 1a recommendation for SGLT2 inhibitors were not prescribed them, researchers reported in the Journal of the American College of Cardiology.

Apixaban and aspirin offered similar protection against major ischemic and hemorrhagic events among people with cancer history and cryptogenic stroke.

Adults with type 2 diabetes have lower risks for death and major adverse cardiovascular and kidney events if they use tirzepatide compared with GLP-1 receptor agonists, according to observational data published in JAMA Network Open.

scPharmaceuticals Inc. announced the FDA approved the supplemental new drug application to expand the indication of its self-administered subcutaneous furosemide injection for patients with heart failure.

Women with mild chronic hypertension induced at 37 weeks’ gestation saw no reduction in adverse maternal outcomes compared with women delivered at 39 weeks, but did experience increases in some neonatal complications, data show.

As your paycheck grows, so does your discretionary spending and saving. While it is easy to spend, it is not always clear where to invest your next dollar intended for future spending.

Ambient air pollution was associated with an increased risk for adverse events among Medicare beneficiaries with preexisting HF, according to a study published in the Journal of the American Heart Association.

Stanford Medicine Children’s Health this year celebrated 50 years of pediatric heart transplants and more than 35 years of pediatric lung transplants, according to a press release.